Researchers Find Bacterial Protein Promotes Cancer
The at the 网红爆料 School of Medicine (UMSOM) announced on Dec. 4 the discovery that DnaK, a protein of the bacterium mycoplasma, interferes with the mycoplasma-infected cell鈥檚 ability to respond to and repair DNA damage, a known origin of cancer.
Little or no mycoplasma DnaK DNA sequences were found associated with the tumor, which was fully developed, suggesting a hit-and-run or hide mechanism of transformation, indicating that the damage is done early, but the protein may not be needed once the cancer cells are formed.
Fiorenza Cocchi, MD, Francesca Benedetti, PhD, Davide Zella, PhD, Robert Gallo, PhD, Sabrina Curreli, PhD, and Selvi Krishnan, PhD
The study was published in the and suggests that bacterial infections may contribute to far more cancers than previously thought. The announcement was made by Robert Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine and co-founder and director, Institute of Human Virology, UMSOM, and Davide Zella, PhD, assistant professor of biochemistry and molecular biology, Institute of Human Virology, UMSOM. Gallo and Zella collaborated with Herv茅 Tettelin, PhD, associate professor of microbiology and immunology, Institute for Genome Sciences, UMSOM.
鈥淐urrently, approximately 20 percent of cancers are thought to be caused by infection, most are known to be due to viruses,鈥� said Gallo. who also is co-founder and director of the Global Virus Network. 鈥淢ycoplasmas are a family of bacteria that are associated with cancers, especially in people with HIV. Our work provides an explanation for how a bacterial infection can trigger a series of events that lead to cancer. Of particular importance, the infection did not need to persist and the protein did not need to be continuously present in all cancer cells. The study also provides a mechanism for how some bacterial infections can interfere with specific cancer drugs.鈥�
Researchers utilized immune-compromised mice as a model for analyzing the effect of mycoplasma infection on the development of lymphoma. They compared how quickly non-infected immune-compromised mice developed lymphoma compared to mycoplasma-infected immune-compromised mice. The mice were infected with a strain of mycoplasma from an HIV patient. The researchers found that mycoplasma infection caused the mice to develop lymphoma earlier in life than non-infected immune-compromised mice and that some, but not all, of the cancer cells had bacterial DNA. Finding only a small amount of bacterial DNA in the cancer cells suggested that the infection did not have to persist to trigger cancer.
鈥淲e focused on a protein called DnaK, which is part of a family of proteins that function as a 鈥榗haperone鈥� for other proteins protecting them from damage or helping them to fold,鈥� Zella said. 鈥淗owever, in this case, DnaK reduces the activity of important cellular proteins involved in DNA repair and anti-cancer-activities, such as p53. Thus, cells infected with mycoplasma would not be able to properly repair damaged DNA, thus, potentially increasing the risk for cancer development.鈥�
The scientists noted that the bacteria can release DnaK and the DnaK enters nearby uninfected cells. The study also demonstrates that by reducing p53, DnaK also can reduce the efficacy of anti-cancer drugs. Thus, mycoplasma infection could not only trigger events leading to the accumulation of DNA damage and oncogenesis in infected cells, but also trigger cancer-causing events in nearby uninfected cells that took up DnaK released from infected neighboring cells.
鈥淲e analyzed the amino acid sequences of DnaK from many bacteria and found that the DnaK proteins from bacteria associated with cancer grouped together were different DnaK sequences from bacteria that are not associated with cancer,鈥� Tettelin said. 鈥淭his raises the possibility that other bacteria have the same cancer-promoting ability.鈥�
According to Gallo, 鈥淭his hit-and-run, or hide, mechanism mediated by a protein common to many cancer-associated bacteria changes how we need to think about infection and at least some cancers. Furthermore, this provides a basis for understanding how infection can influence the effectiveness of some cancer treatments.鈥�
鈥淭his is fascinating science with important implications,鈥� said UMSOM Dean E. Albert Reece, MD, PhD, MBA, who also the executive vice president for medical affairs, 网红爆料, Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor. 鈥淲e are pleased to see a cross-collaboration between two disciplines here at the 网红爆料 School of Medicine. Our Institute of Human Virology鈥檚 basic science laboratory research was aided by the School鈥檚 Institute for Genome Sciences鈥� sequencing expertise, bringing the research to full fruition.鈥�
This research was partially funded by the Maryland Cigarette Restitution Fund (CRF) Program. Morgan State University also participated in this study.
